Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.

Radboud University Medical Center15 enrolled

Overview

Various methods of FDG-PET signal segmentation will be validated by correlation of histopathologically measured tumor dimensions in lymph node dissection specimens of head-and-neck cancer patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Head and Neck Cancer

Interventions

CT-FDG/PET scan of the head-and-neck regionOTHER

CT-FDG/PET scan of the head-and-neck region

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with N+ squamous cell carcinoma of the head and neck, planned for neck dissection. * Age \>18 years. Exclusion Criteria: * Pregnancy. * Women breast feeding

Locations (1)

Radboud University Nijmegen Medical Centre

Nijmegen, Gelderland, Netherlands

RECRUITING

Outcomes

Primary Outcomes

How accurate are the various FDG-PET segmentation tools?

Time frame: Measurements are performed in conjunction with the clinical pathologist directly postoperatively.

Central Contacts

Dominic A.X. Schinagl, MD

CONTACT

NL24-3614515 d.schinagl@rther.umcn.nl

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.